Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Keon Hee Yoo"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood
Mineui Hong, Young Hyeh Ko, Keon Hee Yoo, Hong Hoe Koo, Seok Jin Kim, Won Seog Kim, Heejung Park
Korean J Pathol. 2013;47(2):137-147.   Published online April 24, 2013
DOI: https://doi.org/10.4132/KoreanJPathol.2013.47.2.137
  • 13,567 View
  • 113 Download
  • 30 Crossref
AbstractAbstract PDF
Background

Epstein-Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis (HLH), EBV-positive systemic T-cell lymphoproliferative disease (STLPD) of childhood, and chronic active EBV (CAEBV) infection may develop after primary EBV infection. This study reviewed the clinicopathological spectrum of EBV-associated T- and natural killer (NK)-cell LPD, including STLPD and CAEBV infection, with an analysis of T-cell clonality.

Methods

Clinicopathological features of seven patients with EBV-associated HLH or STLPD and 12 patients with CAEBV infection were reviewed. Immunohistochemical staining and a T-cell receptor (TCR) gene rearrangement study were performed.

Results

STLPD and EBV-positive HLH showed significantly overlapping clinicopathological findings. One patient with STLPD and one patient with EBV-positive HLH demonstrated moderate to severe atypia of the infiltrating lymphocytes, whereas the remaining patients lacked significant atypia. Twelve patients had CAEBV infection, four of whom suffered mosquito-bite hypersensitivity, five showed NK lymphocytosis, and one suffered hydroa vacciniforme. Infiltrating lymphocytes were predominantly small and devoid of atypia. Hemophagocytic histiocytosis was found in seven of 11 patients. Monoclonality was detected in three (50%) of the six patients with successful TCR gene analysis.

Conclusions

EBV-positive HLH and STLPD share similar clinicopathological findings and may constitute a continuous spectrum of acute EBV-associated T- or NK-cell proliferative disorders. The distinction of EBV-positive T-cell LPD from EBV-positive HLH may be difficult during routine diagnoses because of the technical limitations of clonality assessment.

Citations

Citations to this article as recorded by  
  • Die fünfte Auflage der WHO‐Klassifikation – Was ist neu für kutane Lymphome?
    Susanne Melchers, Jana D. Albrecht, Werner Kempf, Jan P. Nicolay
    JDDG: Journal der Deutschen Dermatologischen Gesellschaft.2024; 22(9): 1254.     CrossRef
  • Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues
    Roberto N. Miranda, Catalina Amador, John K.C. Chan, Joan Guitart, Karen L. Rech, L. Jeffrey Medeiros, Kikkeri N. Naresh
    Modern Pathology.2024; 37(8): 100512.     CrossRef
  • Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China
    Dilara Dilmurat, Xinyu Wang, Liwei Gao, Jiao Tian, Junhong Ai, Linlin Zhang, Mengjia Liu, Guoshuang Feng, Yueping Zeng, Ran Wang, Zhengde Xie
    Italian Journal of Pediatrics.2024;[Epub]     CrossRef
  • The fifth edition of the WHO‐Classification – what is new for cutaneous lymphomas?
    Susanne Melchers, Jana D. Albrecht, Werner Kempf, Jan P. Nicolay
    JDDG: Journal der Deutschen Dermatologischen Gesellschaft.2024; 22(9): 1254.     CrossRef
  • An update on Epstein-Barr virus–and human T-lymphotropic virus type-1–induced cutaneous manifestations. CME Part II
    Alejandro A. Gru, Jose A. Plaza, Jose A. Sanches, Denis Miyashiro, Omar P. Sangueza, Francisco Bravo Puccio, Sonia Toussaint, J. Martin Sangueza
    Journal of the American Academy of Dermatology.2023; 88(5): 983.     CrossRef
  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
    Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D. Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici, Amy Chadburn, John K. C. Chan, Wah Cheuk, Wee-Joo Chng,
    Leukemia.2022; 36(7): 1720.     CrossRef
  • Chronic active Epstein–Barr virus enteritis: A literature review
    Yang Shen, Yu Fang Wang
    Journal of Digestive Diseases.2022; 23(5-6): 248.     CrossRef
  • EBV-Associated Lymphoproliferative Disorders
    Young Hyeh Ko
    Clinical Pediatric Hematology-Oncology.2021; 28(1): 14.     CrossRef
  • Clinicopathologic findings of chronic active Epstein–Barr virus infection in adults: A single-center retrospective study in China
    Jing Lin, Haicong Wu, Lei Gu, Xia Wu, Miaofang Su, Haiyan Lin, Bang Liu, Jiaolong Zheng, Xuan Mei, Dongliang Li
    Clinical and Experimental Medicine.2021; 21(3): 369.     CrossRef
  • Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein–Barr virus infection
    Honghao Ma, Liping Zhang, Ang Wei, Jun Yang, Dong Wang, Qing Zhang, Yunze Zhao, Sitong Chen, Hongyun Lian, Li Zhang, Chunju Zhou, Maoquan Qin, Zhigang Li, Tianyou Wang, Rui Zhang
    Orphanet Journal of Rare Diseases.2021;[Epub]     CrossRef
  • Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting
    Jeffrey I. Cohen, Keiji Iwatsuki, Young-Hyeh Ko, Hiroshi Kimura, Irini Manoli, Koichi Ohshima, Stefania Pittaluga, Leticia Quintanilla-Martinez, Elaine S. Jaffe
    Leukemia & Lymphoma.2020; 61(4): 808.     CrossRef
  • EBV-positive T/NK-associated lymphoproliferative disorders of childhood: A complete autopsy report
    JonathanY Keow, WilliamM Stecho, AaronR Haig, NikhilA Sangle
    Indian Journal of Pathology and Microbiology.2020; 63(1): 78.     CrossRef
  • Chronic active Epstein‐Barr virus infection: A heterogeneous entity requiring a high index of suspicion for diagnosis
    Sarah L. Ondrejka, Eric D. Hsi
    International Journal of Laboratory Hematology.2020; 42(S1): 99.     CrossRef
  • Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
    Wook Youn Kim, Ivonne A. Montes-Mojarro, Falko Fend, Leticia Quintanilla-Martinez
    Frontiers in Pediatrics.2019;[Epub]     CrossRef
  • A clinicopathologic study of the spectrum of systemic forms of EBV‐associated T‐cell lymphoproliferative disorders of childhood: A single tertiary care pediatric institution experience in North America
    Amy M. Coffey, Annisa Lewis, Andrea N. Marcogliese, M. Tarek Elghetany, Jyotinder N. Punia, Chung‐Che Chang, Carl E. Allen, Kenneth L. McClain, Amos S. Gaikwad, Nader Kim El‐Mallawany, Choladda V. Curry
    Pediatric Blood & Cancer.2019;[Epub]     CrossRef
  • Unusual lymphoid malignancy and treatment response in two children with Down syndrome
    Ashley Geerlinks, Jennifer Keis, Bo Ngan, Amer Shammas, Reza Vali, Johann Hitzler
    Pediatric Blood & Cancer.2019;[Epub]     CrossRef
  • EBV-Positive Lymphoproliferations of B- T- and NK-Cell Derivation in Non-Immunocompromised Hosts
    Stefan Dojcinov, Falko Fend, Leticia Quintanilla-Martinez
    Pathogens.2018; 7(1): 28.     CrossRef
  • Cutaneous Hematolymphoid and Histiocytic Proliferations in Children
    Alejandro A Gru, Louis P Dehner
    Pediatric and Developmental Pathology.2018; 21(2): 208.     CrossRef
  • Clinicopathological categorization of Epstein–Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications
    Jin Ho Paik, Ji-Young Choe, Hyojin Kim, Jeong-Ok Lee, Hyoung Jin Kang, Hee Young Shin, Dong Soon Lee, Dae Seog Heo, Chul-Woo Kim, Kwang-Hyun Cho, Tae Min Kim, Yoon Kyung Jeon
    Leukemia & Lymphoma.2017; 58(1): 53.     CrossRef
  • Cutaneous EBV-related lymphoproliferative disorders
    Alejandro A. Gru, Elaine S. Jaffe
    Seminars in Diagnostic Pathology.2017; 34(1): 60.     CrossRef
  • T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting
    Dita Gratzinger, Daphne de Jong, Elaine S. Jaffe, Amy Chadburn, John K. C. Chan, John R. Goodlad, Jonathan Said, Yasodha Natkunam
    American Journal of Clinical Pathology.2017; 147(2): 188.     CrossRef
  • Systemic Epstein-Barr Virus-positive T-Cell Lymphoproliferative Disease of Childhood With Good Response to Steroid Therapy
    Do-Hoon Kim, Myungshin Kim, Yonggoo Kim, Kyungja Han, Eunhee Han, Jae Wook Lee, Nack-Gyun Chung, Bin Cho
    Journal of Pediatric Hematology/Oncology.2017; 39(8): e497.     CrossRef
  • Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease
    Paibel Aguayo-Hiraldo, Reuben Arasaratnam, Rayne H. Rouce
    Boletín Médico del Hospital Infantil de México.2016; 73(1): 31.     CrossRef
  • Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host
    Austen J. J. Worth, Charlotte J. Houldcroft, Claire Booth
    British Journal of Haematology.2016; 175(4): 559.     CrossRef
  • Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease
    Paibel Aguayo-Hiraldo, Reuben Arasaratnam, Rayne H. Rouce
    Boletín Médico Del Hospital Infantil de México (English Edition).2016; 73(1): 31.     CrossRef
  • Epstein-Barr Virus–Associated Lymphomas
    Ewelina Grywalska, Jacek Rolinski
    Seminars in Oncology.2015; 42(2): 291.     CrossRef
  • Epstein–Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer/T-cell lymphoma but shows distinctive stem cell-like phenotype
    Siok-Bian Ng, Koichi Ohshima, Viknesvaran Selvarajan, Gaofeng Huang, Shoa-Nian Choo, Hiroaki Miyoshi, Norio Shimizu, Renji Reghunathan, Hsin-Chieh Chua, Allen Eng-Juh Yeoh, Thuan-Chong Quah, Liang-Piu Koh, Poh-Lin Tan, Wee-Joo Chng
    Leukemia & Lymphoma.2015; 56(8): 2408.     CrossRef
  • An uncommon presentation of EBV-driven HLH. Primary or secondary? An ongoing dilemma
    Tânia Serrão, Alexandra Dias, Pedro Nunes, António Figueiredo
    BMJ Case Reports.2015; : bcr2015209615.     CrossRef
  • Hemophagocytic syndromes — An update
    Gritta E. Janka, Kai Lehmberg
    Blood Reviews.2014; 28(4): 135.     CrossRef
  • Epstein–Barr virus‐associated T/natural killer‐cell lymphoproliferative disorders
    Sanghui Park, Young H. Ko
    The Journal of Dermatology.2014; 41(1): 29.     CrossRef
Case Report
Graft-Versus-Host Disease of the Lung after Allogeneic Hematopoietic Stem Cell Transplantation: A Report of Two Cases.
Ji Hyeon Roh, Joungho Han, Keon Hee Yoo, Kang Mo Ahn, Jihye Kim
Korean J Pathol. 2009;43(4):378-381.
DOI: https://doi.org/10.4132/KoreanJPathol.2009.43.4.378
  • 3,023 View
  • 67 Download
AbstractAbstract PDF
Herein, we describe cases of pulmonary acute graft-versus-host disease (aGVHD) in two patients occurring after allogeneic hematopoietic stem cell transplantation (HSCT) due to precursor B-cell acute lymphoblastic leukemia in a 6-year-old patient and in acute myeloid leukemia in a 14-year-old boy. In both cases, chest CT revealed confluent ground-glass attenuation along the bronchovascular bundles, as well as some bronchial dilatation. Microscopically, in both cases we noted a characteristic bronchiolocentric pattern and bronchiolar epithelial changes, which included denudation of the bronchiolar epithelium, regenerating atypical cells, and wall thickening with subepithelial or transmural fibroblast proliferation, along with some lymphocytic infiltration. One patient died on day 86 after allogeneic HSCT due to sudden acute respiratory distress syndrome, and the other patient currently remains alive without active aGVHD. The authors' experiences in these two cases demonstrate that intense awareness of the pathologic findings of GVHD is mandatory after allogeneic HSCT.

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP